1. Home
  2. VKTX vs EPR Comparison

VKTX vs EPR Comparison

Compare VKTX & EPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • EPR
  • Stock Information
  • Founded
  • VKTX 2012
  • EPR 1997
  • Country
  • VKTX United States
  • EPR United States
  • Employees
  • VKTX N/A
  • EPR N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • EPR Real Estate Investment Trusts
  • Sector
  • VKTX Health Care
  • EPR Real Estate
  • Exchange
  • VKTX Nasdaq
  • EPR Nasdaq
  • Market Cap
  • VKTX 3.4B
  • EPR 3.7B
  • IPO Year
  • VKTX 2015
  • EPR 1997
  • Fundamental
  • Price
  • VKTX $23.94
  • EPR $49.27
  • Analyst Decision
  • VKTX Strong Buy
  • EPR Hold
  • Analyst Count
  • VKTX 12
  • EPR 12
  • Target Price
  • VKTX $89.75
  • EPR $50.00
  • AVG Volume (30 Days)
  • VKTX 4.5M
  • EPR 988.7K
  • Earning Date
  • VKTX 04-23-2025
  • EPR 05-07-2025
  • Dividend Yield
  • VKTX N/A
  • EPR 6.98%
  • EPS Growth
  • VKTX N/A
  • EPR N/A
  • EPS
  • VKTX N/A
  • EPR 1.60
  • Revenue
  • VKTX N/A
  • EPR $688,251,000.00
  • Revenue This Year
  • VKTX N/A
  • EPR $0.27
  • Revenue Next Year
  • VKTX N/A
  • EPR $2.69
  • P/E Ratio
  • VKTX N/A
  • EPR $30.79
  • Revenue Growth
  • VKTX N/A
  • EPR N/A
  • 52 Week Low
  • VKTX $18.92
  • EPR $39.87
  • 52 Week High
  • VKTX $81.86
  • EPR $54.25
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 46.06
  • EPR 50.24
  • Support Level
  • VKTX $18.92
  • EPR $48.10
  • Resistance Level
  • VKTX $27.09
  • EPR $49.40
  • Average True Range (ATR)
  • VKTX 2.31
  • EPR 2.09
  • MACD
  • VKTX 0.26
  • EPR 0.05
  • Stochastic Oscillator
  • VKTX 61.44
  • EPR 66.84

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

Share on Social Networks: